| HOME >> BIOLOGY >> TECHNOLOGY |
ADELAIDE, Australia, Aug. 23 /PRNewswire/ --
Highlights
-- Revenue increased 28% over the prior comparable period to A$44.4
million
-- Excluding one-off items EBITDA increased 39% over the prior comparable
period to A$4.6 million
-- Excluding one-off items NPAT increased 24% over the prior comparable
period to A$2.5 million from A$2.0 million
-- Reported NPAT grew to A$4.4 million from A$3.7 million in the prior
comparable period including one-off items
-- Ellex brand product sales grew 55% accounting for 96% of total
revenues, completing the transition from OEM to direct sales
Ellex Medical Lasers Limited (ASX: ELX), a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced its financial results for the year ended 30 June 2007. The results continue to demonstrate strong growth of the business with revenues increasing by 28% over the previous financial year and Net Profit after Tax (excluding one-off items) up 24%.
Commenting on the result, CEO Mr. Peter Falzon said, "We are pleased with the performance of Ellex during the 2007 financial year. The company continues to take market share away from our competitors as we develop our brand and distribution platform for sustained long-term growth. Revenue and market share grew in all regions, with particular strength in Japan and Europe."
The result was achieved despite significant challenges arising from appreciation of the Australian Dollar against the U.S. Dollar and the Japanese Yen.
Following Ellex's successful expansion in Japan, the company recently
stated its intention to expand its direct sales presence in the U.S., the
largest market for its products. To assist in this effort, the company
announced in August 2007 that it has appointed Ms. Christin Harris as Vice
President of U.S. Sales to lead its sales expansion in that market. Ms.
Harris joins Ellex wi
'/>"/>
| SOURCE Ellex Medical Lasers Limited Copyright©2007 PR Newswire. All rights reserved |